Medicon Hellas S.A. (MEDIC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medicon Hellas S.A. (MEDIC) has a cash flow conversion efficiency ratio of 0.074x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.25 Million ≈ $1.46 Million USD) by net assets (€16.95 Million ≈ $19.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Medicon Hellas S.A. for the company's overall valuation and market capitalisation.
Medicon Hellas S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Medicon Hellas S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medicon Hellas S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicon Hellas S.A. ranked by their cash flow conversion efficiency. Explore Medicon Hellas S.A. cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lepidico Ltd
AU:LPD
|
0.000x |
|
Duoback Co. Ltd
KQ:073190
|
-0.023x |
|
Natural Alternatives International
NASDAQ:NAII
|
-0.094x |
|
Xenora Minerals Ltd
AU:XRA
|
-0.038x |
|
CAM Resources Bhd
KLSE:7128
|
0.013x |
|
Binasat Communications Bhd
KLSE:0195
|
0.026x |
|
TPC Power Holding Public Company Limited
BK:TPCH
|
0.062x |
|
Schroder Oriental Income Fund
LSE:SOI
|
0.126x |
Annual Cash Flow Conversion Efficiency for Medicon Hellas S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Medicon Hellas S.A. from 2014 to 2022. View MEDIC stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €16.95 Million ≈ $19.82 Million |
€1.25 Million ≈ $1.46 Million |
0.074x | -77.95% |
| 2021-12-31 | €14.34 Million ≈ $16.77 Million |
€4.79 Million ≈ $5.60 Million |
0.334x | +19.76% |
| 2020-12-31 | €11.03 Million ≈ $12.89 Million |
€3.07 Million ≈ $3.59 Million |
0.279x | +76.73% |
| 2019-12-31 | €10.26 Million ≈ $11.99 Million |
€1.62 Million ≈ $1.89 Million |
0.158x | -52.07% |
| 2018-12-31 | €9.68 Million ≈ $11.32 Million |
€3.19 Million ≈ $3.73 Million |
0.329x | -46.66% |
| 2017-12-31 | €7.84 Million ≈ $9.16 Million |
€4.84 Million ≈ $5.66 Million |
0.617x | +105.22% |
| 2016-12-31 | €6.12 Million ≈ $7.16 Million |
€1.84 Million ≈ $2.15 Million |
0.301x | +586.69% |
| 2015-12-31 | €5.34 Million ≈ $6.25 Million |
€-330.21K ≈ $-386.05K |
-0.062x | -112.35% |
| 2014-12-31 | €3.58 Million ≈ $4.19 Million |
€1.79 Million ≈ $2.10 Million |
0.500x | -- |
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more